Sprint Bioscience is developing autophagy inhibitors for cancer therapy. The impact of autophagy in different diseases attracts strong attention and starting May 23 is the Keystone symposia “Autophagy: Fundamentals to Disease” in Austin, Texas. At that conference Sprint Bioscience will present a poster “Novel Cancer Treatment Targeting Vps34”.
http://www.keystonesymposia.org/index.cfm?e=web.Meeting.Program&meetingid=1253